Who Made the Gains? Here are the top 50 resources stocks for January
Uranium prices have launched into 2024 in the same bullish fashion as 2023; stocks are now responding In a weak month for resources stocks overall, [more…]
FREE WHELAN: And that is why Woolies is short strawberries and no one is ever short Meta
In this Stockhead series, investment manager James Whelan, managing director Barclay Pearce Capital Asset Management, offers his insights on the key investment themes and trends [more…]
The West Arunta: A tale of one mighty explorer and its followers
In remote east-central WA, right on the border of the NT, a niobium-rare earth monster has emerged from the under the spinifex country of the [more…]
MoneyTalks: Two ASX medical imaging stocks are put under microscope – both have big price targets
Ord Minnett believes 4DMedical could double Wilsons Advisory also slaps a big price target on Mach7 4D Medical’s share price could double Ord Minnett [more…]
Lodgers and hammer time: Australia’s property auction market in two acts
CoreLogic – the relentless property data cruncher which apparently never sleeps – says the volume of capital city auctions across Australia fell to a three-year [more…]
How big-hearted EBR Systems is pacing a multi-billion dollar cardiac market
EBR Systems pioneered the WiSE Cardiac Resynchronization Therapy (CRT) system tech, the size of a grain of rice The world’s first pacing system within the [more…]
Why the buzz for kava is growing, and how The Calmer Co. is capitalising
Beyond regulatory hurdles and certain misconceptions, kava is having another moment in the sun In particular, ASX-listed kava product producer The Calmer Co. is starting [more…]
Rise and Shine: Everything you need to know before the ASX opens
Good morning everyone, and welcome to 6 February, 2024 – an important date on the calendar for the 1933 crew of the USS Ramapo, because it [more…]
The Crumbling of Blue Chip Stocks: A Closer Look at the Market’s Hidden Turmoil
Blue chip stocks, traditionally seen as the stalwarts of the investment world, are showing signs of vulnerability, challenging the notion that these shares are a [more…]
Trump’s Supreme Court Challenge: Claiming Immunity Once More
Donald Trump’s latest legal maneuver takes him to the U.S. Supreme Court, where he will argue for reversal of a Colorado court decision that barred [more…]
